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CHAPTER I 
INTRODUCTION 
Calcium plays a critical role in a variety of essential processes 
such as excitation, contraction, blood clotting, enzymatic reactions and 
as a calcium phosphate complex it serves as the supporting comp'onent 
of the vertebrate system. McLean and Hastings (1935) have describea 
the calcium concentration in body fluids as "one of nature's physiological 
t " constan s . The interrelationships among the various calcium compart-
ments and the controls operating to maintain the proper balance among 
them are poorly understood. 
Bone represents by far the largest calcium compartment of the 
vertebrate system and it would be expected that any change in its state 
would be readily reflected in a change in the other compartments6 
especially blood. Then, the physiological regulation of blood calcium 
would be mediated mainly by those factors that influence the formation 
and resorption of bone, namely parathyroid hormone, calcitonin, and 
vitamin D. But there are other factors which have been implicated in 
the control of bone metabol1.sm and plasma calcium._ Thyroxine, 
corticoids:. estrogens and growth hormone affect bone resorption, blood 
and urine calcium and phosphate (Nordin, 1966). The titers of these 
hormones do not change with experimentally induced changes in plasma 
calcium. It is not clear whether their action is a direct or an indirect 
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one or whether they are of importance in the overall physiological 
maintenance of calcium homeostasis. 
The importance of the parathyroid glands in the mediation of cal-
cium homeostasis was recognized by MacCallum and Voegtlin (1908) who 
showed that the removal of the parathyroid glands caused a marked fall 
in serum calcium, and that the tetany associated with the hypocalcemia 
could be relieved by administration of calcium salts. An active para-
thyroid extract able to relieve tetany and restore to normal, the calcium 
and phosphate levels in the blood was prepared by Collip and coworkers 
• 
who also developed a method for its. bio~ssay (Collip, 1925; Collip et al. 
1925; Collip and Clark, 1925a, b). 
Albright an_d Reifenstein ( 1948) considered the primary effect of 
parathyroid hormone to be on the phosphate dissolved in the body 
fluids. The hormone would affect the phosphate in such a way as to 
make it more readily excreted by the kidneys with a resulting decrease 
in serum phosphate level. Resorption of the hydroxyapatite of bone 
would, therefore, increase resulting in an elevated serum calcium •. 
According to this hypothesis the administration of parathyroid hormone 
results in a rise in serum calcium because of a primary effect on phos-
phate excretion. 
In.the second hypothesis developed by McLean and Urist (1955), 
- 3 -
bone was considered as the primary target of parathyroid hormone 
action with an indirect effect on the tubular reabsorption of phosphate. 
A negative feedback mechanism was proposed to regulate the hormone 
secretion. A low blood calcium titer would evoke an increased para-
thyroid hormone release, which would in turn effect calcium mobiliza-
tion from bone to raise the serum calcium to the normal level; a high 
blood calcium titer would reduce the release of parathyroid hormone 
and the consequent bone resorption~ 
Rasmussen (1961) pointed out that a mechanism of blood calcium 
• 
,, regulation based only on the parathyroid· glands and their effect on bone 
would lead to wide fluctuations in blood calcium because of the slow 
and extended response of bone to parathyroid hormone, by increasing 
tubular re absorption of calcium and distal tubular secretion of phos -
phate. Rasmussen believed that the kidney may be responsible for the 
rapid control of small fluctuations in plasma calcium. Sanderson et al. 
(1960} observed that in intact dogs blood calcium would return to the 
initial level within a few hours after it had been raised by the admin-
istration of calcium or lowered by the administration of EDTA. In 
parathyroidectomized animals, however, it had not returned to the initial 
levels in 24 hours. 
During perfusion experiments designed to test the hypothesis of 
- 4 -
and Urist (1955), Copp and Davidson (1961) and Copp et al. 
(i961, 1962) obtained results similar to those of Sanderson. The feed-
back hypothesis could explain the difference. in the response to hypo-
calcemia. consequent to EDTA administration, between the normal and 
parathyroidectomized animals. Hypocalcemia would stimulate parathyroid 
hormone synthesis and release, which in turn would increase calcium 
mobilization from bone, .and the blood calcium would return to its initial 
level; in parathyroidectomized animals the absence of the parathyroid 
glands results in the observed lack of calcium return to its initial level. 
• 
The time difference for calcium to retur.n to its initial level observed 
between the normal and parathyroidectomized animals after induced 
hypercalcemia by administration of calcium chloride cannot be explained 
by the simple hypothesis that high levels of calcium suppress para-
thyroid hormone secretion. If this were so. the response should be 
similar in both the normal animal, where parathyroid hormone output 
has been inhibited, and in the parathyroidectomized animal, which lacks. 
\ 
parathyroid hormone. Using the dog as the experimental animal, Copp 
et al. (1962) showed that during hypercalcemia the parathyroid glands 
produce a hypocalcemic factor. which he named calcitonin. 
Hirsch, Gautier and Munson (1963) and Macintyre, Foster and 
Kumar (1965) confirmed the existence of a hypocalcemic factor, but 
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found that it was secreted by the thyroid glands. Hirsch et al. (1963) 
called the thyroid factor. thyrocalcitonin. Foster. Macintyre and 
pearse (1964) and Pearse (1965) suggested that thyrocalcitonin was 
synthesized by the parafollicular cells of the thyroid, and Pearse (1966) 
introduced the term C cells (C for calcitonin) for these cells. Immuno-
fluorescence studies {Bussolati. Carvalheira and Pearse. -1967) have 
demonstrated the presence of calcitonin in the C cells of the thyroid 
glands of the guinea-pig. The C cells of the thyroid glands are large. 
have an oval nucleus and contain spherical granules in their cytoplasm 
• 
(Non~dez, 1932). Matsuzawa and Kurosumi (1967) in a study of the 
morphology of the C cells demonstrated that the granules are released 
by hypercalcemic stimulation. 
In a study of the embryology of the C cells. Carvalheira and 
Pearse (1967) established that these cells originate from the last pair 
of pharyngeal pouches and are present in all vertebrates except the 
cyclostomes. _ In bony fishes. elasmobranchs. amphibia, reptiles and 
birds, these cells remain separate from the thyroid glands and form 
the ultimobranchial bodies. It appeared that, at least. in some birds 
and reptiles some of these cells migrate ·to the thyroids as evidenced 
" - by extraction of calcitonin from both the ultimobranchial bodies and the 
thyroid. Copp et al. (1967) were able to extract calcitonin from the 
--- -
r:: 
r r 
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k ultimobranchial bodies of chickens and Moseley et al. ( 1968) extracted 
·~.: 
calcitonin from the ultimobranchial bodies of the chicken, pigeon and 
' ( 
the African skink (Mabuya striato). TheY: .found that in the chicken and 
skink most of the calcitonin was found in the ultimobranchial bodies, 
whereas in the pigeon it was found in equal amounts in both the 
ultimobranchial bodies and thyroid glands. Clark ( 1968) identified 
calcitonin in the ultimobranchial bodies of turtles (Crysemis picta and 
'· 
Pseudemys scripta). 
/ .... ~ 
:.. ., 
Calcitonin seems to exist in at least four forms, designated alpha, 
• 
beta, gamma and delta; the four calcitoriins differ in their elution 
patterns on Sephadex gels (Gudmundsson, 1967} and the C-terminal 
praline of beta calcitonin does not have an amide group. The a -
calcitonin from porcine thyroid glands has been purified and its amino 
acid sequence determined (Potts et al. 1968; Neher et al. 1968). The 
sequence has been confirmed by the chemical synthesis of the poly-
peptide (Rittel et al. 1968). The polypeptide has 32 amino acids and a 
molecular weight of 3585 (Figure 1). The pure peptide has an activity 
of 200-250 Medical Research Council units/mg dry weight (Kahnt et al. 
1968).. One MRC unit is defined in terms of a Standard Preparation, 
10 milliunits of which produce a 10% fall in plasma calcium when 
administered intravenously in a 150 gm rat (Kumar et al. 1965). 
' 
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Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-
1 2 3 4 5 6 7 8 9 
Ser-Ala-Tyr-Trp-Arg-Asn-Leu-Asn-
10 11 12 13 14 15 16 17 
Asn-Phe-His-Arg-Phe-Ser-Gly-Met-
18 19 20 21 22 23 24 25 
• 0 
// 
Gly-Phe-Gly-Pro-Glu-Thr-Pro-C 
26 27 28 29 30 31 32 ~H 
2 
FIGURE 1. AMINO ACID SEQUENCE 
OF PORCINE ALPHA-CALCITONIN 
(Potts et al. 1968). 
.. 
. 
. 
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t· The calcitonin peptide has several distinctive structural features 
{Potts et al. 1968). The single tyrosine and tryptophane residues are 
adjacent; the number of charged amino acids is quite low. There is a 
1-7 intrachain disulfide bridge, providing a 23-membered ring at the 
amino-terminus. The carboxyl-terminal amino acid is prolinamide. 
The terminal disulfide group and the alpha-carboxyl amide are analogous 
structural features found in oxytocin and vasopressin. What portions of 
calcitonin are necessary for biological and immunological activity are 
not yet known; however, methionine {residue 25) may be alkylated or 
oxidized without loss of biological activ.ity {Brewer et al. 1968). The 
serine, glycine and proline constitute 35% of the amino acid residues 
in the molecule; isoleucine is absent {Potts et al. 1967). 
There seem to be some species differences with respect to the 
chemistry and biological activity of calcitonin. Tashjian and Munson 
(1965} found that antiserum to porcine calcitonin produced in rabbits 
neutralized pig and calf calcitonin but had no effect on the activity of 
calcitonin from rats, monkeys or man. , Likewise, the difficulty in 
demonstrating hypocalcemic activity of porcine calcitonin in man may 
be due to differences in the calcitonin o( the two species; in fact human 
calcitonin from C cell tumors has been isolated and the amino acid 
sequence determined {Neher et al. 1968) and it was found that even 
- 9 -
though the disulfide bridge between position 1 and 7, and the C-terminal 
proline amide are the same as in porcine alpha-calcitonin 18 amino 
acid residues are "different throughout the. ;molecule. Arginine and 
tryptophane are absent, lysine and isoleucine are found in position 18 
and 27 respectively. and methionine changes its place from position 25 
to 8. Pigeon calcitonin seems to be different from porcine calcitonin, 
since it has a different elution pattern than porcine calcitonin on 
Sephadex (Moseley et al. 1968). More evidence for species differences 
comes from the report that two porcine and one avian (chicken) 
• 
calcitonin preparations, which had equal· activities in the rat, were found 
to differ when tested in the mouse. One porcine and the avian prepara-
[ i· tion were ten and five times, respectively, more potent than the other 
porcine preparation {Parson and Reynolds, 1968). 
Calcitonin acts on both bone and kidney. Kenny (1964) and Hirsch 
I 
Voelkel arid Munson ( 1964) showed that calcitonin decreases serum 
phosphat,e and that the administration of calcitonin was followed by a 
phosphaturia (Kenny and Heiskell, 1965; Milhaud, Moukhtar, Cherion 
and Perault, 1966; Robinson, Martin and Macintyre, 1966). The renal 
effect, . however, requires doses 10-100 times higher than those 
necessary to produce hypocalcemia (Russell and Fleish, 1967). The 
hypophosphateII1ia produced by calcitonin is not entirely due to an in-
~-. 
[ 
l· 
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creased excretion of phosphate, but also to increased phosphate de-
position in bone; in fact, hypophosphatemia is still observed in nephrec-
tomized rats (Robinson, Martin, Matthews and Macintyre, 1967). The 
exact nature of the renal effect is not known, and it may be secondary 
to increased parathyroid hormone secretion (Stahl et al. 1966). 
Several investigators have attempted to clarify the relationship 
between calcitonin and parathyroid hormone. Hirsch et al. (1964) 
reported that parathyroidectomy did not affect the hypocalcemic or the 
hypophosphatemic response to calcitonin. Gitelman et al. (1965) con-
.. 
firmed Hirsch's findings. Gudmundsson· et al. (1966) observed that after 
parathyroidectomy, rats maintained on a normal diet did not exhibit the 
hypocalcemic effect of calcitonin but did exhibit the hypophosphatemic 
response. When the parathyroidectomized rats were maintained on a 
high calcium, low phosphate diet both the hypocalcemic and hypophos-
phatemic effects of calcitonin were observed. . Milhaud et al. (1966), 
however, obtained results which showed that parathyroidectomy in rats 
maintained on a normal diet abolished only the hypophosphatemic effect. 
•. 
Stahl and Kenny (1967) have reported that thyroparathyroidectomy in the 
dog abolished the hypophosphatemic response of calcitonin, and calcitonin. 
administration in the thyroparathyroidectomized dogs caused a relative 
hyperphosphatemia. On the other hand, the hyperphosphaturic effect in 
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the rat is not abolished by thyroparathyroidectomy (Milhaud et al. 1966) 
or parathyroidectomy (Robinson, Martin and Macintyre, 1966). 
The hypocalcemic effect of calcitonin. is due to its inhibitory 
action on calcium mobilization from bone. Friedman and Raisz (1965) 
studied the effect of calcitonin on isolated embryonic rat bones which 
had been pre-labeled in vivo with 45ca. These investigators found that 
the addition of calcitonin to the culture medium decreased the release 
of 45ca from the bone; when both parathyroid hormone and calcitonin 
were added to the medium the effect was more pronounced. Histological 
• 
examination showed that calcitonin diminished the fibroblastic and osteo-
elastic proliferation stimulated by parathyroid hormone. A similar, but 
less marked, change was observed in the culture to which parathyroid 
hormone was not added. Aliapoulios et al. (1966) demonstrated an 
inhibition of resorption in calvariae from 5-day old mice when calcitonin 
was added to the incubation medium. Calcitonin does not act as an 
inhibitor of parathyroid hormone. Reynolds et al. (1967) found that the 
changes in the osteocyte~ and osteoblasts brought about by parathyroid 
hormone or vitamin A could not be prevented by calcitonin, but calci-
tonin would inhibit the increase in osteoclasts. No changes were ob-
~, served in hydroxyproline and hexosamine levels of mouse calvariae 
~: 
h 
l-w-h_e_n_c_al_c_i_t_o_n-in_w_a_s_a_d_d_e_d_t_o_t_h_e_c_ul-tu_r_e_m_e_d_i_um _ · __ I_n_p_a_r_a_t_h_y_r_o_i_d_e_c_to_-__ 
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roized rats, Foster et al. {1966) noted a drop is osteoblasts after pro-
longed treatment with calcitonin. 
The evidence for an effect of calcitonin on bone formation is un-
clear and contradictory. Raisz et al. (1967) observed no increase in 
the deposition of calcium from the medium into bone when calcitonin 
was added to the incubation medium of embryonic cultures of radii and 
ulnae. Gaillard (1967} observed an increase in osteoblasts in cultures 
treated with calcitonin, and Gaillard and Thesingh (1967) observed a 
net increase in the length and width of in vitro cultivated radius rudi-
• 
ments from 15-day old mouse embryos :when calcitonin was added to 
the cultivating medium. These investigators also cultivated frontal 
bone from 18-day old chick embryos together with thyroid tissue of 8-
day old chick embryos and observed an increase in the growth of the 
>;-: 
· cultured bones. These observations indicate that the thyroid tissue of 
an 8-day old empryo releases some factor (probably calcitonin) that in-
duces an increase in the width of bone as compared to controls. In 
contrast to Gaillard's results, Baylink, Morey and Rich {1969) using 
histological methods concluded that calcitonin decreases both the forma-
tion and resorption of bone. Goldhaber et al. (1968) reached the same 
conclusion from investigations which showed that calcitonin reduces the 
incorporation of tritiated proline into bone in culture systems. Nisbet 
' . 
• 
<. ;
' 
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and Nordin (1967), on the other hand, found that calcitonin did not 
change the uptake of proline-C-14 suggesting that bone formation is not 
affected. 
Studies on the metabolism of bone are of very little help in 
establishing whether bone formation is affected by calcitonin. Bexter 
et al. (1968) reported that calcitonin increased the in vitro synthesis of 
-- ----
glucosaminoglycan, indicating an increase in bone formation. Johnston 
and Deiss (1966} incubating calvarfae from young adult rats showed that 
calcitonin decreased glucose utilization and lactate production. In-
• 
soluble ·hydroxyproline was also decreased; hexosamine was reduced but 
not significantly. Klein and Talmage (1967) demonstrated that calcitonin 
reduces the serum hydroxyproline and the wash hydroxyproline of 
peritaneal lavage. Martin, Robinson and Macintyre (1966) and Aer (1968} 
found that calcitonin reduces urinary hydroxyproline excretion. 
The increase in citric acid following the administration of para-
thyroid hormone has been well documented. Nisbet and Nordin (1967) 
in an in vitro system in which cal variae were incubated, studied the 
relation between calcitonin and citric acid. They found that less citric 
acid accumulated in the medium when pa;r-athyroid hormone and calcitonin 
•-. were added to the cultures than when parathyroid hormone alone was 
added. The differences observed in the incubation medium were not 
- 14 -
reflected in the calvariae themselves. 
The mode of action of calcitonin on bone is unknown. It does not 
act by inhibiting parathyroid hormone, since it acts in the absence of 
the parathyroid glands; it does not have any effect on ribonucleic acid 
(Gudmundsson et al. 1966; Tashjian, 1965). The hypothesis that it may 
increase the rate of the de novo synthesis of some enzyme does not have 
any experimental support. 
Four possibilities have been considered which need not be 
exclusive of each other. First, the hormone both in vitro and in vivo 
.. 
has been shown to reduce the number of' osteoblasts (Friedman and 
Raisz, 1965; Reynolds et al. 1967; Matrajt et al. 1967). Such changes 
in the cellular makeup of bone could account for the hypocalcemic 
effect of the hormone. No data is available on the time such changes 
occur after hormone administration; the studies available have been 
done after the animals had been chronically treated with calcitonin or 
after bone cultures had been incubated for days in a medium containing 
calcitonin. The hypocalcemic effect, however. is manifest 15 minutes 
after the hormone is administered. It is not known whether the cellular 
changes occur within such short a period of time or whether more 
subtle functional shifts occur at the molecular level · and precede the 
f.'· morphological changes. 
~-
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A second hypothesis has been advanced by Wells and Lloyd (1968b) 
who found that imidazole produces a drop in blood calcium and antago-
nizes the hypercalcemic effect of parathyroid extract (Wells and Lloyd, 
1968). Imidazole activates adenosine 3', 5'-phosphodiasterase, the 
enzyme which degrades cyclic 3'. 5' -adenosine monophosphate. Previous!~ 
Wells and Lloyd (1967) showed that theophylline, which inhibits 
adenosine 3'. 5' -phosphodiasterase. produced hypercalcemia. Chase and 
Aurbach (1967, 1968) ·showed that p·arathyroid hormone stimulates the 
urinary excretion of cyclic adenylate which is dependent upon a direct 
.. 
action of the hormone on the kidneys. Wells and Lloyd (1968b) pro-
posed that the level of cyclic AMP in bone cells mediates the rate of 
calcium mobilization and, secondarily, the level of serum calcium. 
Elevations of cyclic AMP level brought about by parathyroid hormone, 
theophylline or other drugs. increase the mobilization of calcium; a 
decrease in cyclic AMP. brought about by calcitonin, or imi:dazole, 
would decrease calcium mobilization. Substantiation of the hypothesis 
proposed by Wells and Lloyd can be found in the work of Chase and 
Aurbach (1968). These investigators have reported that parathyroid 
hormone increases adenyl cyclase activity in bone 3 to 5 fold; 
calcitonin, however, does not seem to affect cyclase activity. 
A third hypothesis involves the regulation of pH at the cellular 
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level. It has long been known that parathyroid hormone increases acid 
production. Recently Nisbet and Nordin (1967) observed that citric acid 
levels are reduced in bone culture media when calcitonin is present, 
and the reduction is more marked when resorption is stimulated by 
parathyroid hormone. Calcitonin may increase the pH at the cellular 
level and decrease calcium mobilization. 
Finally. Doty, Schofield and Robinson (1968) observed that acid 
. phosphatase and ATPase are affected by calcitonin and parathyroid hor-
mone in an opposite manner. Parat11,yroid extract increased the acid 
phosphatase of metaphyseal bone an~ the ATPase of osteoclasts, whereas 
calcitonin decreased the levels of these enzymes. These enzymes may 
be involved in the mechanism of action of calcitonin; acid phosphatase 
has been implicated as an important factor in the calc:ification process 
'·. i. 
(Cartier, 1951). How these enzymes are related to bone formation and 
resorption: is unknown. 
Alip.poulios et al. (1966) have shown that extracts of human thyroid 
glands contain hypocalcemic activity and Barrett et al. (1968) has puri-
fied human calcitonin and found that it was stable and soluble at neutral 
pH, whereas porcine calcitonin is not. In man calcitonin-like activity 
has been detected also in the thymus and parathyroid glands (Macintyre, 
1968). Abnormal calcitonin states are suspected to be involved in 
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carcinoma of the thyroid gland, pseudoparathyroidism and 
hyperparathyroidism. Increased calcium-lowering activity in either 
blood or tumor tissue or both have been fpund. Removal of the tumor 
results in decreased levels of circulating calcium lowering activity 
(Milhaud et al. 1968; Cunliffe et al. 1968; Melvin and Tashjian, 1968). 
The hypocalcemia associated with pseudohypoparathyroidism is believed 
to be caused by excessive secretion of calcitonin. Aliapoulios et al. · 
(1966) and Tashjian et al. (1966) have shown that thyroid tissue from 
patients with pseudoparathyroidism contains approximately 100 times 
-
more calcitonin-like activity than normat thyroid tissue. Tetany and 
diffuse non-toxic goiter was found to be associated with increased 
calcitonin levels and thyroidectomy resulted in disappearance of the 
syndrome (Mazzuoli et al. 1966). 
The therapeutic uses of calcitonin have not yet been explored in 
great detail. A serious hindrance to studies on the possible clinical 
ap~lication of calcitonin is the fact that normal man responds poorly to 
porcine calcitonin, at the present the main source of the hormone 
{Foster et al. 1967; Milhaud et al. 1965; Bell et al. 1966). Calcitonin 
elicits a weak hypocalcemic response in .osteoporotic patients {Foster 
et al. 1968). In a patient with Paget's disease the administration of 
calcitonin was found to relieve the pain {Bijvoet and Jansen, 1964). 
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The secretion of calcitonin in response to hypercalcemic states 
has been well documented (Talmage et al. 1965; Toverod et al. 1966; 
Hirsch and Munson, 1966). In fact it was the result of perfusion studies 
.. 
with hypercalcemic blood that led Copp to postulate the presence of a 
.. hypocalcemic factor (Copp et al. 1962). There has been some question 
as to whether the hormone is secreted continuously or only in response 
to hypercalcemia. Talmage et al. (1965) postulated that calcitonin 
secretion occurred at .normal plasma calcium levels. It has now been 
demonstrated that secretion of calcitonin occurs at normal and sub-
.normal calcium levels (Deftos, Lee and Potts, 1968). It has also been 
established that the plasma calcium controls the levels of circulating 
V calcitonin (Care et al. 19 69). 
STATEMENT OF THE PROBLEM 
A study of the in vitro biosynthesis of calcitonin would be of value 
in attempting to define those conditions which in the organism control 
the synthesis and release of the hormone. There have been a number 
of studies of the in vitro· biosynthesis of polypeptide hormones. · ·Bauer 
and Lazarow (1961) and Mallory et al. (1964) have reported the incor-
poration of radioactive amino acids into insulin using goosefish islet 
~-· 
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and rat pancreas, respectively. More re.cently Steiner and Oyer 
and Steiner et al. (1967) using rat pancreas and islet cell tumor 
demonstrated the incorporation of labeled amino acids into insulin 
and a precursor molecule. Takabatake and Sachs (1964) reported the in 
vitro biosynthesis of vasopressin by hypothalamic tissue. Wool et al. 
-
(1961) and Adiga et al. (1965) using various labeled amino acids demon-
strated the in vitro biosynthesis of ACTH in anterior pituitary tissue. 
Wakabayashi and Tamaoki (1967) have reported the synthesis of LH by 
isolated anterior pituitary glands and have studied the effect of androgens 
.. 
the synthesis. 
By using the general experimental approach used for the bio-
synthesis of these polypeptide hormones we propose to synthesize cal-
citonin in an ovine thyroid slice system. Glycine-C-14 will be used as 
the tracer amino acid. Calcitonin titers in the blood are thought to be 
controlled by the levels of calcium; high levels of calcium inducing an 
increase and low levels inducing a decrease in the circulating calcitonin. 
'. 
,:.'. 
In perfusion studies of the thyroid glands (Care et al. 1968; Lee et al. 
1969) it has been shown that in vivo an increase in the calcium concen-
tration of the perfusing medium resulted in increased circulating hypo-
calcemic activity. 
Since. in vivo ~he increased hypocalcemic activity. obtained in the 
r~ ·. 
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high calcimn perfusion studies, may have been the result of synthesis, 
or both, we will study the effect of calcium on the synthesis 
effect of calcium on the release of the hormone in the in vitro 
synthesizing system to establish the role of these ions on calcitonin 
biosynthesis and release. Since it has been reported that magnesium 
affects the synthesis of parathyroid hormone (Buckle and Care, 1967), 
we will also study the effect of magnesium on the synthesis of calcitonin 
in the ovine thyroid slices. 
~ . 
t 
~ . 
::.' .· 
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CHAPTER II 
MATERIALS AND METHODS 
GENERAL EXPERIMENTAL PROCEDURE 
In the first part of this work our main purpose was to develop 
a system for the incorporation of glycine-C-14 into proteins. of ovine 
thyroid slices, and more specifically the isolation, from the slices of 
calcitonin containing a radioactive amino acid. For this purpose ovine 
thyroid glands were obtained from the slaughterhouse as soon as 
.. 
possible after the animal was killed - - 1,J.Sually 10-20 minutes. The 
* glands were placed in cold Krebs-Ringer bicarbonate buffer (pH 7. 4) 
and were brought to the laboratory where they were dissected free from 
fat. connective tissue. and other adhering structures, then washed with 
cold Krebs-Ringer bicarbonate buffer (pH 7. 4) and cut with a Stadie-
Riggs plastic tissue slicer into slices approximately O. 5 - 1. O mm in 
thickness. The slices were then transferred into a series of 50 ml 
Erlenmeyer flasks (approximately 2. O gm of slices per flask) containing 
10 ml of Krebs-Ringer bicarbonate buffer (pH 7. 4) to which was added 
~~ 
The phrase "Krebs-Ringer bicarbonate buffer" whenever used later in 
this dissertation means a Krebs-Ringer bicarbonate buffer to which was 
added glucose (320 mg/ 100 ml) and all the amino acids of calcitonin 
(20 mg/liter) with the exception of the one used as a tracer. 
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glucose (320 mg/ 100 ml) and all the amino acids of calcitonin (20 mg/ 
liter) but the tracer. To each flask 2. 5 µCi of the tracer amino acid 
The incubation was carried out at pH 7. 4 in a constant 
0 
shaker water bath at 37 C for 4 hours. Flasks which contained, in 
addition to the above, 1. O ml of 50% trichloroacetic acid served as 
controls. The incubation of the experimental flasks was terminated by 
addition of 1. 0 ml of trichloroacetic acid to each flask. 
The tissue slices after incubation were cut into small pieces with 
scissors and washed 10 times with cold acetone, 6 times with cold 
• 
chloroform and again 10 times with cold' acetone. The defatted tissue 
was then driec;l at room temperature and stored at 4° C until it was 
used. 
The defatted tissue was then extracted with 10 volumes of 8. O M 
urea - 0.1 N cysteine in O. 2 N HCl for one hour at room temperature. 
The mixture was then squeezed through. cheese cloth and washed with a 
volume of doubly-distilled water equal to that of the extraction solution. 
The filtrate and washings were combined and dialyzed against O. 1 M 
0 
acetate buffer (pH 4. 6) for 24 hours at 4 C. To the dialysate was 
then added 3. O M NaCl to a final concentration of 1. O M. After stand-
ing for 72 hours at 4° C the precipitate was collected by centrifugation 
0 
at 4 C at 1400 RCF for 3 hours. The inactive precipitate was dis-
~' : 
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and to the supernatant was added solid NaCl to a final concen-
of 2. O M. After 72 hours at 4° C the active precipitate was 
0 . . 
collected by centrifugation at 4 C at 1400 RCF for 3 hours. The 
precipitate was then dried by lyophilization. The dried material was 
then purified on Sephadex columns. 
Radioactivity and biological activity were measured at each step 
during the isqlation. Biological activity was estimated by the hypo-
calcemic response to the injection of the test material in rats. Radio-
activity was measured by liquid scintillation counting (Beckman LS 
,,. 
250 Liquid Scintillation Spectrometer) ana total protein was determined 
by a modification of the Lowry method. 
Once we were able to show that calcitonin is synthesized in vitro 
we studied the effect of high concentrations of calcium on the synthesis 
and the release of the hormone. The effect of high concentrations of 
magnesium on the synthesis of calcitonin was also studied. In this 
part of our investigation, the slices were incubated in normal, high 
calcium, or high magnesium media. To assess the extent of synthesis 
the slices were extracted and calcitonin isolated through the second 
sodiun;l chloride precipitation step. The lyophilized material was dis-
solved in O. 1 M acetic acid and injected intravenously into rats. The 
fall in serum calcium at 50 minutes was taken as the index of hypo-
": r. 
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calcemic activity. The difference between the hypocalcemic activity of 
glands incubated in normal and high calcium or high magnesium was 
taken as representing the extent of synthesis. To measure the amount 
of released hormone at the end of the incubation the slices were re-
moved and the media was injected into rats for bioassay; the. fall in 
serum calcium 50 minutes after the administration of the calcitonin 
preparation was taken as the index of hypocalcemic activity released into 
the medium. 
.. 
CHEMICALS 
Acetic Acid, Glacial, J. T. Baker Chemical Company, No. 9507. 
Acetone, Mallinckrodt Chemical Works, AR No. 2440. 
Amino Acids, L form, · Mann Research Laboratories, Inc. , (M.A.) 
Kit 00100-721. 
Albumin, Crystalline, Pentex, Inc., Lot No. 16. 
Blue Dextran 2000, Pharmacia Fine Chemicals, Inc., No. 4474. 
Calcein Indicator. Fisher Scientific Company, No. C-566. 
Calcium Carbonate, Mallinckrodt Chemical Works, AR No. 4071. 
Calcium Chloride • 2 H20, Mallinckrodt Chemical Works, AR No. 4160. 
Chloroform, Mallinckrodt Chemical Works, AR No. 4440. 
Copper Suliate • 5 H20, Mallinckrodt Chemical Works, AR No. 4844. 
·.:·,' 
-~ 
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L-(+)-Cysteine Hydrochloride, Eastman Organic Chemicals, No. 2367. 
Dextrose. Anhydrous, Mallinckrodt Chemical Works. AR No. 4912. 
p-Dioxane. (stabilized), Mallinckrodt Chemical Works, AR No. 4937. 
Disodium Ethylenediamine Tetracetate, Versenes, Inc. 
Folin-Ciocalteu Phenol Reagent, Harleco. 
Formic Acid 88%, Mallinckrodt Chemical Works. AR No. 2592. 
14
c-Glycine (UL), Nuclear-Chicago, Batch No. 14, S. A. 108 mc/mM. 
Tracerlab, Lot No. 78-81-2, S •. A. 70 mc/mM. 
Hydrochloric Acid, J. T. Baker Chemical Company, No. 9535. 
,, 
Magnesium Sulfate · 7 H20, Mallinckrod~ Chemical Works, AR No. 6056. 
Naphthalene, Matheson, Coleman and Bell, NX5. 
Pentobarbital Sodium, Abbott Laboratories, No. 3117. 
Potassium Phosphate Monobasic, Mallinckrodt Chemical Works, AR No. 
Potassium Sodium Tartrate, Mallinckrodt Chemical Works, AR No. 2367. 
Sephaciex G_::.._f_O_Q, Pharmacia Fine Chemicals, Inc., No. 6164. 
Sephadex G-50, Superfine, Pharmacia Fine Chemicals, Inc., No. 5739. 
Sodium Acetate, Anhydrous, J. T. Baker Chemical ·company, No .. 3742. 
Sodium Bicarbonate, Mallinckrodt Chemical Works, AR No. 1412. 
Sodium Chloride, Mallinckrodt Chemical Works, AR No. 7581. 
Sodium Cyanide, J. T. Baker Chemical Company, No. 1144. 
Sodium Hydroxide, Mallinckrodt Chemical Works, AR No. 7708. 
.J 
' ~~" 
e;· 
ti· 
1' 
• 
• 
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Trichloroacetic Acid, Mallinckrodt Chemical Works, AR No. 2928. 
Mallinckrodt Chemical Works, AR No. 8648. 
PREPARATION OF INCUBATION MEDIA 
Krebs-Ringer bicarbonate buffer or a modification thereof served 
. . 
as the medium for the incubation. Normal composition of the Krebs-
Ringer bicarbonate buffer is as follows: 
100 part (s) o. 90% (0. 154 M) .. 
4 " 1.15 rr 
3 " 1.22 (0. 110 M) 
1 II 2. 11 (0. 154 M) 
1 II 3.82 II 
21 " 1.30 " 
* \ Final concentration 
.,,, 
NaCl solution (0. 118 M) .... 
.,,, 
KCl " (0. 0047 M) 
.... 
CaC12 
II {0.0025 M)* 
KH2S04 " (0.0012 M)* 
MgS04 
. 7H20 (0. 0012 M) * 
solution 
NaHC03 " (0.0248 M) * 
Ionic strength· = q. 1600 
= 
( ++ Mg = 
11. 51 mg/100 ml) 
3. 7 mg/ 100 ml) 
Twenty milligrams of each of the amino acids of calcitonin (with 
the exception of the tracer) and 3. 2 grams of glucose were added to 
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each liter of buffer. An oxygen-carbon dioxide (95%:5%) mixture was 
bubbled into the medium for fifteen ininutes and the pH was adjusted to 
7. 4 before it was used for incubation. 
Modifications of the above mentioned Krebs-Ringer bicarbonate 
buffer were prepared to serve as high calcium and high magnesium 
.· media by increasing the calcium and magnesium ion concentration in 
i. 
such a way that calcium. ion plus magnesium ion concentration were 
approximately equal. The final compositions of the modified buffer 
solution were as follows: 
High-calcium medium 
100 part (s) o. 90% (0. 154 M) 
12 " 1.22 (0.110 M) 
4 II 1. 15 (0. 154 M) 
1 " 2.11 " 
1 II 3.82 " 
21 " 1. 30 II 
:.:~ 
Final . concentration 
• 
NaCl solution * (0. 1180 .M) 
CaC12 
KCl 
II 
" 
KH SO '' 2 4 
* (0. 0101 M) 
* (0.0047 M) 
* (0. 0012 M) 
MgSO 4 • 7 H20 (0. 0012 M)* 
solution 
NaHC03 
II (0. 0248 M) 
Ionic strength = O. 1838 
= 
( ++ Mg = 
45. 6 mg/ 100 ml) 
3. 7 mg/ 100 ml) 
i,c 
1----------~ 
'· 
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High-magnesium medium 
100 part (s) o. 90% (0. 154 M) 
·3 II 1.22 (0.110 M) 
4 " 1.15 {O. 154 M) 
1 If Z.11 II 
8 II 3.82 II 
II 1.30 {O. 154 M) 
*Final concentration 
.... 
NaCl solution (0.1180 M>"' 
C~Cl2 II 
KCl II 
KH2P04 
II 
MgS04 • 7H20 
solution 
II 
.... 
(0.0025 M)"' 
* (0. 0047 M) 
..,. 
{0.0012.M)"' 
* {O. 0089 M) 
* (0. 0248 M) 
Ionic strength = 0. 1838 
= 11. 51 mg%) 
( ++ Mg = 29.78 mg%) 
TISSUE PREPARATION AND INCUBATION 
OVine thyroid glands were obtained from the slaughterhouse 
(Chicago Lamb Packing Company, 3907 Halsted Street, Chicago, IDinois) 
between nine and ten o'clock in the morning and usually 10-20 minutes 
after sacrifice the glands with all adhering tissues were placed in cold 
Krebs-Ringer bicarbonate buffer (pH 7. 4) and brought to the laboratory 
where they were dissected free from fat, connective and other adhering 
tissue and sliced in the cold into slices approximately O. 5 - 1. O mm in 
thickness with a Stadie-Riggs tissue slicer. The elapsed time between 
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·sacrifice and incubation was usually four hours. The slices were 
weighed and about two grams were placed in each of a series of 50 ml 
Erlenmeyer flasks. Each flask contained 10 ml of Krebs-Ringer bi-
carbonate buffer and 2. 5 p.Ci of the labeled glycine. Some flasks con-
in addition to the above, 1. O ml of 50% trichloroacetic acid and 
as controls. The gas phase for all incubations was air, and 
incubations were carried out in a hood. 
All incubations were carried out in a temperature controlled 
0 
shaker water bath at 37 C for 4 hours . 
• 
Incubations were terminated by the ·addition to the flasks of 1. O ml 
50% TCA or by placing the slices into cold acetone. 
To determine the effect of high calcium and high magnesium ions 
on synthesis and release of hormones, the incubations were carried out 
in buffer containing normal (11. 4 mg Ca++/ 100 ml; 3. 7 mg Mg++/ 100 
ml), high calcium (45. 6 mg Ca++ I 100 ml; 3. 7 mg Mg++ I 100 ml) and 
high magnesium (4.51 mg Ca++ /100 ml; 29.78 mg Mg++ /100ml) con-
centrations. After incubation, aliquots of the high calcium medium were 
assayed for calcitonin activity to determine the release of the hormone 
from the slices. The slices were extracted for calcitonin through the 
second sodium. chloride fractionation step. The material obtained was 
lyophilized", dissolved in O. 1 M acetic acid buffer (pH 4. 6) and assayed 
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for hypocalcemic activity. 
EXTRACTION, ISOLATION AND PURIFICATION OF CALCITONIN 
When the incubations were terminated, the slices were minced with 
scissors and washed ten times with cold acetone, six times with cold 
chloroform and again ten times with cold acetone. The resulting lipid-
free tissue was dried at room temperature (Rasmussen, 1959) and 
stored in a desiccator, unless immediately used. The acetone dried 
material was weighed and extracted with ten volumes of 8 M urea - 0. 1 
N. cysteine in _o. 2 N HCl (Rasmussen,.· 1964). The isolation and purifi-
cation of the extract follows the pr9cedure of Gudmundsson, Macintyre 
Ji: 
and Soliman (1966). The mixture was stirred and allowed to stand for 
•. 
.. 
· one hour at room temperature. It was then filtered through cheese 
cloth and the residue washed with doubly distilled water (10 ml/gm dry 
powder). The washings were combined with the filtrate and were 
. dialyzed against O. 1 M sodium acetate buffer (pH 4. 6) for 24 hours at 
4° C. ['he dialyzate was made up to 1. 0 M with respect to sodium 
chloride with 3. 0 M NaCl and allowed to stand at 4° C. After 72 hours 
the precipitate (inactive) was removed by centrifugation (1400 R. C. F.) 
' . 0 for 3 hours at 4 C. Solid sodium chloride was added to the super-
natant to a final concentration of 2. 0 M. After standing for a further 72 
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at 4° C the precipitate was collected by centrifugation (1400 
0 for 3 hours at 4 C. The precipitate was dried by lyophiliza-
The dried precipitate was dissolved in O. 1 M forrnic acid (18 mg/ 
and applied to a 2. 5 x 45 cm column of Sephadex G-100 and eluted 
with the same solvent. The transmission of the effluent at 280 mµ was 
monitored with a Uvicor?- Absorptiometer and Recorder (LKB Instruments, 
Inc., Rockville, Maryland) and fractions were collected on a Gilson 
Fraction Collector v15 {Gilson Medical Electronics, Middleton, 
,,. 
Every fourth fraction was assayed for hypocalcemic 
When one fraction containing hypocalcemic activity was found, 
the fractions preceding and following that fraction were assayed for 
hypocalcemic activity until one fraction on either side was found not to 
, contain biological activity. The fractions containing hypocalcemic 
activity -were pooled, lyophilized and stored at 4° C until used. The 
dried material was dissolved in 1. O M formic acid and applied to a 
\ 
O. 9 x 45 cm column of Sephadex G-50 superfine and eluted with a 
solution of 0 .. 1 M formic acid - 1. O M urea - O. 2 M sodium chloride. 
For biological activity the dried material was appropriately dissolved in 
O. 1 M acetic acid and assayed. The fractions from the Sephadex G-50 
column were scanned for hypocalcemic activity (vide supra); the 
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containing hypocalcemic activity were pooled, lyophilized and 
biological activity determined. A diagram of the fractionation and 
· .. purification procedure is shown in Figure 2. 
To assess the purity of the fractions containing hypocalcemic 
an aliquot from each fraction was chromatographed on thin 
layer cellulose sheets {Eastman Chromatogram Sheet 6065, cellulose 
with fluorescein indicator). For chromatography 50 µl of each fraction 
was applied to a sheet and developed with the upper phase of a butanol: 
acetic acid: water (4:1:5} system for 2. 5 hours. The combined fractions 
" 
were also chromatographed. Two dimensional chromatography was done 
" on the combined fractions on cellulose thin layer sheets. 2 5 µl of the 
combined fractions. were applied on one corner of the sheet and 
developed in one direction with a butanol: acetic acid: water system and 
in the other direction with a propanol: water {70:30 v/v) system. The 
(, migration of the sample applied was determined with a UV lamp. ~.·. 
' ~<~ 
~· To characterize further the biological active peptide 100 µl (4 µg 
protein) of the combined fractions containing hypocalcemic activity from 
the Sephadex G-50 column were subjected to hydrolysis with 6. O N 
0 HCl for 24 hours at 110 C. The hydrolyzate was evaporated to dry-
ness, redissolved in water and again evaporated to dryness; the dry 
material w·as dissolved in O. 01 N HCl and analyzed for amino acids on 
,•· 
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MINCED THYROID SLICES 
FILTRATE 
+ 
Extraction 
(10 x with cold acetone 
6 x with cold chloroform 
10 x with cold acetone} 
RESIDUE (dry at room temperature) 
Extraction 
10 volumes 8. 0 M urea - O. 1 N 
cysteine - O. 2 ,N HCl 
1 hour at room temperature 
Filter through cheese cloth 
RESIDUE 
wash with 10 
volumes water 
WASHINGS ___________ ....,.._ _ __ 
Dialyze against 
O. 1 N acetate buffer (pH 4. 6) 
- 0 24 hours 4 C 
DIALYSATE 
Add 3. O M NaCl 
to make a 1. O M 
Allow to stand 72 hr 4° C 
Centrifuge 3 hr 1400 RCF 
Precipitate 
(Inactive} 
SUPERNAT~NT 
Residue 
-
Figure 2. · Flow Diagram for Fractionation and Purification of Calcitonin 
!_igure 2, continued 
~ r ·t t jprec1p1 a e 
; (Inactive) 
PRECIPITATE 
(active) 
Lyophilize 
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I 
SUPERNATANT 
Add solid NaCl to make 2. O M 
Allow to stand 72 hr 4o C 
Centrifuge 3 hr 1400 RCF 
Supernatant 
Dissolve in O. 1 M formic acid 
Apply to Sephadex G-100 
Elute with 0. 1 M formic acid 
.. 
ACT! E FRACTIONS 
ACTIVE FRACTIONS 
Lyophilize. Dissolve in 1. O M formic acid 
Apply to Sephadex G-50 superfine column. 
Elute with 0.1 M formic acid - 1. O M urea -
O. 2 N HCl 
Thin layer chromatography 
Amino acid analysis 
"· 
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Amino Acid Auto analyzer. 
DETERMINATION OF SERUM CALCIUM 
A method for determining ionizable calcium in serum by Ashby 
Roberts was modified for use in this work. Blood samples were 
obtained from rats by tail bleeding. The tail was placed in warm 
water for about one minute, a quarter of one-half inch of the tail was 
cut with a sharp blade and the blood collected. The blood was placed 
in the refrigerator for about one hour before the clot was separated 
from the serum by centrifugation for two minutes in a Beckman Spinco 
Microfuge. Thirty microliter aliquots of serum were added to micro-
titrator cups; to each cup were added 150 microliters of 0. 002 M 
EDTA, one drop (about 60 microliters) of properly diluted calcein 
indicator~ one drop of 1% sodium cyanide solution, and one drop of 1. 0 
N sodium hydroxide. Titrations were performed with a Beckman 
Spinco Microtitrator filled with a 20. O mg% standard calcium solution. 
A long wave ultraviolet lamp (Mineralight, Model SL 3660) was placed 
about 2 inches above the titration cup. The standard calcium solution 
was added with continuous stirring until a green fluorescence appeared. 
The calcium concentration of the sample is directly proportional to the 
difference in mforoliters of standard calcium solution required to 
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the sample and to titrate a water blank. A 12. O mg% standard 
solution was titrated with each group of samples, and the calcium con-
centrations were calculated as follows: 
mg% calcium = 12. 0 mg% x microliters for unknown 
microliters for 12. 0 mg% standard 
microliters for unknown = microliters of titrant required to titrate 
blank minus microliters of titrant required 
.. 
to titrate unknown sample 
microliters for 12. 0 mg% = microliters of titrant required to titrate 
standard 
blank minus microliters of titrant 
required to titrate 12. 0 mg% standard 
Figure 3 indicates the linear relationship between the microliters 
of titrant used and the concentration of calcium and the data for this 
standard curve appears in Table I. 
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TABLE I 
Standard Curve Data for Calcium Determination 
Calcium No. of Microliters Microliters 
mg% Samples of Titrant (Titrant - 0 mg%) 
~ + 0 Blank 29.31 - 0.13 -----
6 23.62 + 5.69 4 - 0.26 
" 
6 5 20.29 + - 0.13 9.02 
6 17.66 + 11.65 8 - 0.19 
6 14.69 + 14.62 10 - o. 08 
12 6 11. 59 + - 0.13 17.72 
14 4 8.77 + - 0.15 20.54 
16 5 5.67 + - 0.13 23.64 
~.· 
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solutions 
Calcein solution-concentrated: O. 25 gm of powdered indicator was 
dissolved in 40 ml of 1. O N NaOH. The solution was diluted to 1000 ml 
with doubly distilled H20. 
Calcein Indicator solution: 0. 5 ml of the concentrated calcein solution 
was diluted to 2 5 ml with doubly distilled water. 
Calcium standard solution (20 mg%): O. 2497 gm of oven dried calcium 
. carbonate was dissolved in 30 ml of 2 N HCl and diluted to 500 ml with 
doubly distilled water. Working solutions were prepared from this 
• 
stock solution. 
Ethylenediaminotetraacetic acid: 187. 5 mg of Na2EDTA was dissolved 
in C02 -free H20 to a total volume of 500 ml. 
PROTEIN ANALYSIS 
Protein was determined according to the method of Lowry (1951) 
as modified by Oyama and Eagle (1956). One milliliter of reagent "C" 
was placed in each of 9 x 75 mm test tube. To each tube was added 
200 µl of sample {water for the blanks), the contents were mixed and 
alloweP, to stand for 10 minutes. Then q. 1 ml of Folin-Ciocalteu re-
agent was added to each tube with mixing. The tubes were allowed to 
stand for 30 minutes and the transmittance read at 750 mµ on a 
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DU spectrophotometer. A standard curve was prepared 
the same procedure using bovine serum albumin as standard. 
for the calibration curve are giv.e.n in Table II and the 
standard curve appears in Figure 4. 
The transmittance is converted to optical density and the density 
of the reagent blank is subtracted from that of the experimental and 
standard tubes. 
the formula: 
OD 
u 
The concentration of the unknown is calculated using 
X (concentration of standard) X 5 = protein/ml of unknown 
OD sample 
s 
"· Solutions 
I· Reagent A: 20 gm of Na2co3 • 4 gm of NaOH and 200 mg of 
KNaC4H~06 · 4H20 were dissolved in one liter of doubly distilled water. 
~eagent B: 5 gm of CuSO 4 · 5 H20 were dissolved in one liter of 
doubly distilled water. 
Folin-Ciocalteu Reagent: Folin-Ciocalteu Reagent was obtained 
commercially from Fisher Scientific Company and diluted with doubly 
distilled H20. The dilution (usually 5:7) giving the highest optical 
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TABLE II . 
Standard Curve Data for Protein Determination 
No. of 
OD750 Albumin {µg) Determinations 
5 6 0.0873 
10 6 0.1634 
20 6 0.1634 
30 5 0.4036 
40 6 0.5393 
50 5 0.6025 
r---------------~ ~·-
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density that was stable for two hours was selected. 
I 
Reagent C: Fifty parts of reagent A and one part of reagent B were 
mixed fresh on the day of use. 
Measurement of Radioactivity 
A Beckman LS-250 Liquid Scintillation Spectrometer was used for 
all the radioactivity determinations. Samples were counted in twenty-
two milliliter low potassium-40 content glass vials with tin-foil lined 
plastic screw caps. Ten milliliters of the desired scintillation fluid 
were placed in each vial. To the sc!i.ntillation fluid was added an 
appropriate amount of the sample and the sample was counted five times 
for five minutes each time. 
The scintillation fluid was prepared by dissolving 4. 0 gm of PP 0 
and 100. O gm of naphthalene in p-dioxane and made up to the volume of 
one liter. 
DETERMINATION OF BIOLOGICAL ACTIVITY 
Male Holtzman rats weighing from 100 to 110 _grams (Holtzman 
Company. Madison. Wisconsin) were kept in the laboratory and fed 
. 
standard rat chow until they reached a weight of 140 to 170 grams at 
which time they were used for determination of biological activity of 
calcitonin preparations. 
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The animals were anesthetized with sodium pentobarbital injected 
intraperitoneally at a dose of 5 mg per 100 grams of body weight. A 
blood sample was collected from the tail. .. The animal was placed on an 
operating board, an incision was made along the thigh to expose the 
femoral vein. 250 µl of calcitonin preparation, or vehicle, was injected 
into the vein using a Hamilton syringe of appropriate size, except for 
the experime!:!tS to determine the effect of calcium on calcitonin release 
from the thyroid slices when 150 µl of incubation medium or buffer was 
injected into the vein. The incision 11as then closed with wound clips. 
After fifty minutes, while the animal was still under anesthesia, another 
blood sample was collected. 
The blood was allowed to remain in the refrigerator for about 
one hour for .clot formation. It was then centrifuged for two minutes to 
separate the serum. The serum was analyzed for calcium and the 
difference between the calcium at zero time and fifty minutes was used 
as an index of the effect of the material administered. 
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CHAPTER ill 
EXPERIMENTAL RESULTS 
The experimental portion of this work comprises two parts. These 
include the biosynthesis and purification of calcitonin, and the bioassay 
of the synthesized material. In the biosynthesis and purification studies, 
a system for the incorporation of glycine-C-14 into ovine thyroid slices 
was developed.. The slices were then subjected to isolation and purifica-
tion procedures to obtairi a highly purified calcitonin preparation. The 
medium used for the incubation was krebs -Ringer bicarbonate buffer, 
pH 7. 4, to which was added glucose and the amino acids of calcitonin 
to stimulate protein synthesis and calcitonin synthesis in particular. 
The second part of this work comprised the study of the effects of 
high calcium and high magnesium concentrations on the synthesis and 
release of calcitonin from the thyroid slices. This was done in an 
attempt to define the conditions which control the synthesis and release 
of the hormone. 
The Effect of the Addition of Glucose and Amino Acids of Calcitonin to 
the Incubation Medium on the Incorporation of Glycine-C-14 in Thyroid 
Proteins. 
One gram of ovine thyroid slices was incubated with 1. 25 p.c of 
r r-
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glycine-C-14 (UL) in 25 ml Erlenmeyer flasks containing 5. O ml of 
buffer. 0 The incubations were carried out at 37 C for 4 hours in a 
constant temperature shaking water bath.. The gas phase was air. The 
incubations were terminated with the addition of one milliliter of 50% 
trichloroacetic acid. The slices were homogenized in distilled water 
and 100 µl of the homogenate was counted in a liquid scintillation mix-
ture containing 6% Cab-0-Sil {Packard Instruments Company, Downers 
Grove, Illinois). The protein in the homogenate was determined and 
the radioactivity expressed in disintegrations per minute per milligram 
.. 
protein. 
The data on the effect of glucose and the amino acids of calcitonin 
are presented in Table ID. It is readily evident that the radioactivity 
represents true incorporation since the slices in the "killed" fl.asks 
show negligible radioactivity. It is also evident that glucose markedly 
stimulates the incorporation of glycine-C-14 into the thyroid tissue, the 
increase above the basal level is approximately 200%. The addition of 
the calcitonin amino acids alone has no significant effect on the isotope 
incorporation. The addition of both glucose and amino acids increases 
incorporation with respect to the basal level (102%). However, a de-
crease in the incorporation of the radioactive label is observed when 
compared to the medium with glucose alone. 
TABLE III 
Effect of Glucose and Calcitonin Amino Acids on the Incorporation of Glycine-C-14 
in the Proteins of Ovine Thyroid Slices 
No. of 
*** Medium Incubations DPM/100 mg Tissue DPM I mg Protein % Change 
:>le 8963 :: + Killed 8 90 84 - 8 -----
** 
+ + Basal 8 30275 - 300 3283 - 33 -----
+ + ~ Basal + glucose 8 79527 - 795 10207 - 102 + 211 -,) 
• 
Basal + amino acids 8 30484 ::. 30 5 3804 :: 380 + 16 
Basal + glucose 
+ + 
+ amino acids 7 60957 - 610 6623 - 662 + 102 
* Killed refers to flasks to which 1. O ml of 50% TCA was added to the medium at the start 
of incubation. 
** . Basal refers to those flasks containing only Krebs-Ringer bicarbonate buffer with no additions. 
**>~ % Change is the change in DPM/mg protein over the basal level. 
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In all subsequent incubations we used the medium to which glucose 
and the amino acids of calcitonin were added. We believe that the de-
crease in incorporation observed with this _medium was due to a de-
crease in the incorporation of label into proteins requiring other amino 
acids besides those of calcitonin. The lack of these amino acids de-
pressed the synthesis of those proteins requiring other amino acids in 
addition to those added, whereas the synthesis of those proteins and 
polypeptides made up only of the amino acids of calcitonin would be 
accelerated. When glucose alone was added the synthesis of many 
• 
small peptides would result with very few complete proteins formed, 
since the only source of essential amino acids would be the pool of 
amino acids present in the slices and from the breakdown of other 
proteins. 
The Synthesis of Calcitonin in Krebs-Ringer Bicarbonate Buffer Con-
taining Physiological Concentrations of Calcium. 
To determine whether calcitonin was being synthesized at physio-
logical concentrations of calcium, ovine thyroid slices were incubated in 
Krebs-Ringer bicarbonate buffer containir:ig 11. 5 mg calcium per 100 ml 
of buffer. 18 to 20 grams of slices were found necessary to extract an 
amount of· calcitonin sufficient for the assay of hypocalcemic activity. 
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For this experiment, 20 grams of slices were i!lcubated in Krebs-
Ringer bicarbonate buffer in 2. O gram quantities in 50 ml Erlenmeyer 
flasks containing 10 ml of buffer. The incubations were carried out in 
an atmosphere of air at 37° C for 4 hours and were terminated with 
the addition of 1. O ml of 50% trichloroacetic acid to each flask. 
The incubated glands and 20 grams of unincubated glands were 
extracted and calcitonin was isolated through the second sodium 
chloride precipitation step. The active precipitate was lyophilized, 
dissolved in O. 1 M acetic acid and the hypocalcemic activity assayed in 
,,. 
140-170 gram Holtzman rats. The rats' were fasted 18 hours before 
assay. Each rat received intravenously 250 µl of the calcitonin 
preparation which contained 125 µg of lyophilized material. The calci-
tonin preparations were analyzed for protein content and the change in 
serum calcium was expressed as !:::.. Ca per 10 µg protein. Comparison 
of the decrease in serum calcium (Table IV) obtained with the calcitonin 
preparation obtained from incubated and unincubated glands shows that 
only a small difference statistically not significant (0. 11 mg% Ca) 
exists. This finding is in accord with in vivo observations which indi-
• 
cate that at physiological serum calcium concentration only small 
amounts of calcitonin are present in the circulation. 
" 
. ~·· 
ti"'. 
~; 
"' ~r 
i' 
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TABLE IV 
fl:vpocalcemic Activity of Calcitonin Preparations Isolated from Unincubated 
Ovine Thyroid Glands and from Thyroid Slices Incubated in Krebs-Ringer 
Bicarbonate Buffer Containing Physiological Concentrations of Calcium. 
UNINCUBATED GLANDS 
Ca mg% 
Animal t t50 
6.Ca mg% 6.Ca/10 µg 
No. 0 mg%/Protein 
i ii.46 11. 27 - 0.19 - 0.22 
l 11.52 10.44 1. 08 1. 23 
-3 11. 78 11.47 - 0.31 0.36 
4 11.44 10.73 - 0.71 - 0.81 
s 11.86 11.31 0.56 0.64 
+ + Mean - s. e • 0.65 - 0.17 
INCUBATED GLANDS 
Ca mg% 
Animal 
to t50 
6.Ca mg% 6.Ca/10 µg 
No. mg% /Protein 
i 12.04 11.30 - 0.74 - 0.87 
2 11.. 45 11.22 0.23 0.27 
3 11.97 11.36 - 0.61 - 0.71 
4 12.20 11.54 - 0.66 - 0.78 
5 12. 12 .. 11. 10 - 1.02 - 1.19 
+ + Mean - s. e. - 0.76 - 0.15 
r--------------------51---------------------
r 
~'·: 
~ ... 
~: 
..... 
The Effect of High Calcium Concentrations on the Synthesis of Calcitonin 
by Ovine Thyroid Slices. 
Since calcitonin titers in the circulat~on seem to be controlled by 
the serum calcium concentration. and since at physiological concentra-
tions of calcium no net synthesis was observed, it became apparent that 
if a significant amount of synthesis was to be observed, the calcium con-
centration in the incubation media would have to be increased. Krebs-
Ringer. bicarbonate buff er was prepared such that the calcium ion concen-
tration was. 45. 6 mgs per 100 ml of buffer. To eliminate any variation 
• 
which may have existed in the content of calcitonin of the glands due to 
the source and age of the animals, food ingested and season of sacrifice. 
incubations in buff er containing physiological and high concentrations of 
calcium were carried on at the same time. 
After incubation the glands were pooled and calcitonin isolated 
through the second sodium chloride precipitation step. The precipitate 
was lyophilized. dissolved in O. 1 M acetate buffer and its hypocalcemic 
activity assayed in 140-170 gram rats. 
When the amount of calcitonin is determined, the preparation ob-
tained .from glands incubated in Krebs-Ringer bicarbonate buffer contain-
ing high concentrations of calcium (45. 6 mg%) show higher hypocalcemic 
activity than those preparatfons obtained from glands incubated in Krebs-
r; ______ ---w 
f ~.·· 
L, 
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~ Ringer buffer containing physiological concentrations of calcium (11. 5 
mgo/o) (Tables V and VI). 
· The net effect has in each case been calculated by adding to the 
effect of the administered preparation the effect of the vehicle alone 
that of O. 1 M acetic acid. As shown in Table VII, the vehicle alone 
raised the serum calcium by an average of O. 55 mg. The decrease 
in serum calcium is greater for the three preparations obtained from 
the glands incubated in buffer containing high calcium concentrations 
than for those incubated in buffer containing physiological calcium con-
• 
centrations. The fall in serum calcium i~ 4. 9%. 5. 0% and 6. 2% for 
the three preparations respectively. 
A comparison of the hypocalcemic activity of the calcitonin 
preparations obtained from slices incubated in buffer containing physic-
logical concentrations of calcium with preparations obtained from glands 
incubated in buffer containing high concentrations of calcium shows that 
the difference of the means of preparations 2 and 3 is statistically 
significant at the 5% level or less, as ·evaluated by a Student's "t" 
Test. The significance of the difference of the means of preparation 1 
is questionable and lies between the 10 ar.id 5% level. 
These findings support the in vivo studies which show that hyper-
calcemia increases the circulating calcitonin activity. 
~ 
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TABLE v 
Hypocalcemic Activit;y of Calcitonin Isolated from Ovine 
Th;yroid Slices Incubated in Krebs-Ringer Bicarbonatlr 
Buffer Containing Ph;ysiological Calcium Concentrations 
Preparation Animal Ca mg% Ca/10 ~g Net % 
No. 
to t5o 
mg% /Protein Change Change 
1 - 1 11.52 11. 04 - 0.45 - 1. 00 8.9 
2 12.13 11. 89 - 0.23 - 0.78 6.5 
3 11.88 10.82 - 1.00 - 1. 55 13.1 
• 6.3 4 12. 13 11.92 - 0.20 - 0.75 
+ 1.02 + 0.18 Mean - s. e. - - 8.7 
2 - 1 9. 97 8.25 - 1.43 - 1.88 20.0 
2 9.76 8.63 - 0.93 - 1.48 15.2 
3 10.87 9.98 - 0.73 - 1. 28 11.9 
+ 1.55 + 15. 7 Mean - s. e. - - 0.18 
3 
-
1 12.04 11.30 - 0.87 - 1.43 11.8 
- 2 11.45 11.22 - 0.27 - 0.83 7.2 
3 11.97 11. 36 - 0.71 - 1.26 10.6 
4 12.20 11.54 - 0.78 - 1.33 11.0 
5 12.11 11. 10 - 1. 19 - 1. 74 14.5 
+ 1.31 + 11.0 Mean - s. e. - - 0.15 
•, 
'. 
" 
( 
rt 
•" 
?':' 
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TABLE VI 
Hypocalcemic Activity of Calcitonin Isolated from Ovine 
Thyroid Slices Incubated in Krebs-Ringer Bicarbonate 
Preparation . Animal Ca mg% Ca/10 µg Net 
No. 
to t50 
mg% /Protein Change 
1 - f 10.37 9.97 - 0.35 - 0.90· 
2 10.65 9.74 - 0.82 - 1. 37 
3 12.73 10. 19' 2.25 - 2.80 
.4 12.01 10.06 - 0.84 - 1. 39 
+ 1. 61 + 0.41 Mean - s. e. -
2 
-
f 1.1.12 9.38 - 2.22 - 2.77 
2 11.06 9.61 - 1.22 - 1.77 
3 10.89 8.86 - 1.72 - 2.27 
+ 
- 2.25 + 0.29 Mean - s. e. -
3 - 1 11. 47 10.54 - 1.10 - 1.65 
2 11.78 10.74 - 1. 22 - 1.77 
3 12.76 10.91 - 2.17 - 2.72 
4 11.52 10.24 - 1.50 - 2.05 
5 12.38 11.03 - 1. 56 - 2.11 
+ 2.06 + Mean - s. e. - - 0.18 
% 
Change 
8.8 
12.0 
22.1 
11. 6 
13. 6 
25.0 
16. 1 
20.9 
20.7 
14.5 
15. 1 
21.4 
17.9 
17.9 
17.2 
r:-
.....--
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TABLE VII 
-
The Effect. of the Vehicle (0. 1 M -Acetic Acid) for the 
-
: Calcitonin Preparations on the Serum Calcium of Rats 
,. 
. 
·,: 
: Ca mg% 6.Ca mg% Animal 
No. to t50 <to - t5o) 
. 
• 
1 12.60 12.<)4 + 0.34 
, 
2 12.31 13.26 + 0.95 
t 
~r 3 12.53 13. 12 + o. 59 F r· 
. 4 11.56 11.93 + 0.37 
5 10.78 11.27 + 0.49 
Mean + 0.55 + 0.11 - s. e. + -
I 
·. 
~ . 
.. 
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!he Effect of High Magnesium Concentrations on the Synthesis of 
Calcitonin by Ovine Thyroid Slices. 
-
This experiment was designed to determine whether the stimulation 
· of calcitonin synthesis, observed when the glands were incubated in 
Krebs-Ringer bicarbonate buffer containing high concentrations of cal-
cium, was due to a specific or a non-specific effect of calcium. For 
this purpose the Krebs-Ringer bicarbonate buffer was prepared such 
that the level of magnesium was increased eight times, and at the same 
time the sum of the magnesium and calcium ions was approximately 
equal to the sum of the calcium and magnesium ions in the Krebs-
Ringer bicarbonate buffer containing high concentrations of calcium .. 
Magnesium was chosen because its serum level is affected by parathy-
roid hormone- the same as is calcium and in some cases it seems to be 
able to substitute for calcium; in fact, administration of magnesium is 
followed by an increased elimination of skeletal-bound radioactive cal-
cium (Clark and Geoffray, 1958); furthermore, in vitro (Schachter and 
Rosen, 1959; Hendrix et al. 1963) and in vivo studies (Alcock and 
Macintyre, i962) suggest that magnesium and calcium act as competitors 
in inte.stinal absorption. 
The procedures for incubations, isolation and assay of hyper-
calcemic activity were the same as those used for the demonstration of 
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the effect of calcium. In both preparations (Tables VIII and IX) there 
*':. 
is a small increase in hypocalcemic activity, but the difference of the 
means is not significant. Preparations incubated on the same day in 
Krebs-Ringer bicarbonate buffer containing physiological, and high con-
centrations of magnesium are compared in Table X. It is evident that 
magnesium has very little effect on the synthesis of calcitonin; the 
small increas_e in hypocalcemic activity may be due to the substitution 
of magnesium for calcium in processes not involved with calcitonin 
f·. synthesis, thus fre~ing more calcium to exert its effect on the biosyn-
f • 
f:. thesis of calcitonin. The data is summarized in Table XI. 
Effect of High Calcium Concentrations on the Release of Calcitonin from 
Ovine Thyroid Slices. 
The in vivo studies do not distinguish whether the increase in cir-
culatiJ!.g calcitonin is a result of increased synthesis, enhanced release 
or both. To determine whether calcium affected the release of calci-
tonin, two gram quantities of ovine thyroid slices were· incubated in 50 
ml Erlenmeyer flasks containing Krebs-Ringer bicarbonate buffer with 
either physiological or high concentrations of calcium. The incubations 
0 
were carried on in an atmosphere of air at 37 C for 4 hours and were 
terminated by removing the tissue from the flasks. The medium from 
. ' 
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TABLE VIII 
H;y,eocalcemi c Activit;y of Calcitonin Pre:earations Isolated 
from Slices Incubated in Krebs-Ringer Bicarbonate Buffer 
Concentrations of 
\ 
Containing Ph;ysiological Magnesium . 
. 
Preparation_ Animal Ca mg% 6.Ca/10 µg Net % 
; : No. 
to t5o 
mgo/o I Protein Change Change 
1 1 10.75 10.44 - 0.41 - 0.96 9.0 
• 
-2 10.94 10.61 - 0.49 - 1.04 9.6 
3 11.10 9. 9 5 - 1.65 - 2.21 19.9 
+ 1.40 + Mean - s. e. - - 0.42 
,. 
2 1 12.04 11.30 - 0.87 - 1. 42 11.8 
2 11. 45 11. 22 - 0.27 - o. 82 7.2 
3 11. 97 11. 36 - 0.71 - 1.26 10.6 
-
4 12.20 11.54 - 0.78 - 1.33 11.0 
5 12.11 11.10 - 1.19 - 1.74 14.5 
.. 
+ 1.31 + 0.15 Mean .... s. e . . - -
-
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TABLE IX 
Hypocalcemic Activit;y: of Calcitonin Pre;earations Isolated from 
Ovine Th;y:roid Slices Incubated in Krebs-Ringer Bicarbonate 
Buffer Containing High Concentrations of Magnesium. 
Preparation Animal Ca m'i!!'/o 6.Ca/10 µg Net % 
No. 
to t5o 
mg% /Protein Change Change 
f 
-
1 f1.06 9. 82 - 1.64 - 2.19 - 19.9 
• 
. 
2 10.93 10.34 - 0.77 - 1.32 - 12.2 
3 11.13 10.15 - 1.31 - 1. 86 - 16.8 
+ 1.. 7 8 + Mean - s. e. - - 0.25 
z 
-
1 11.95 11.06 - 1.12 - 1.67 - 14.9 
2 11. 59 11.04 - 0.70 - 1.25 - 10.8 
3 12.84 11. 26 - 2.00 - 2.56 - 20.0 
4 11.56 11.03 - 0.67 - 1.22 - 10.6 
5 11.34 11. 69 - 0.82 - 1.37 - 11.7 
+ 1.61 + Mean - s. e. - - 0.24 
r 
------------------------------------------------------------------------
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TABLE X 
Hypocalcemic Activity of Calcitonin .Preparations Isolated from 
Slices Incubated in Krebs-Ringer Bicarbonate Buff er Containing 
Physiological or High Concentrations of Calcium and Magnesium 
Animal 
No. 
1 
2 
3 
4 
5 
+ Mean - s. e. 
* 
* p 
Physiological 
- 1.43 
- 0.83 
- 1.27 
- 1.34 
- 1.75 
+ 
- 1.31 - 0.15 
Net 6.Ca mg% 
Hjgh Magnesium High Calcium 
- 1. 78 - 1.66 
- 1. 25 - 1.78 
- 2. 57 - 2.73 
- 1.23 - 2.06 
- 1. 38 - 2.12 
+ 
- 1.62 - 0.25 - 2 .. 06 -: o. 18 
N. S. 0.01 - 0.005 
Probability of the significance of the diff ere nee determined by use of 
a Student's "t" Test. 
·.~-
--
Y'· 
1 - N 
2 - N 
3 - N 
1 
- N 
2 - N 
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TABLE XI 
Summary of the Data on the Effect of Caleium 
and Magnesium on the Synthesis of Calcitonin* 
Net 6. Ca mg% (mean) 
10 µg Protein 
++ ++ Normal High Ca or Me-
+ 1 1.61 + - 1. 02 - 0.18 - HC - 0.41 
+ 0.18 2 - 1.55 - - 2.25 
+ 
H<; - ·- 0.29 
1.31 + 0.15 3 HC 2.06 + 0.18 - - - - -
+ + 
- 1.40 - o. 42. 1 - HM 1.78 - 0.25 
1.. 31 + 0.15 2 1.62 + 0.24 - - - HM - -
** p 
0.1 
-
0.05 
0.05 
0.01 
-
0.005 
. N.S. 
N. S. 
; * Explanation of Symbols. 
N - Preparations obtained from slices incubated in Krebs-Ringer 
bicarbonate buff er containing physiological concentrations of 
calcium and magnesium. 
HC Preparations obtained from slices incubated in buffer containing 
high concentrations of calcium. 
HM - Preparations obtained from slices incubated in buffer·. containing 
.high concentrations of magnesium.· 
**Probability of .the significance of the difference of the means as deter-
mined by the use of a Student's "t" Test. 
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flask was assayed for hypocalcemic activity in two rats. Each rat 
received 150 µl of incubation medium. The control rats received 150 µl 
of normal or high calcium Krebs-Ringer bicarbonate buff er. The 
results are presented in Tables XII, XIII and XIV. 
The adµlinistration of normal buffer, which contained 676 µg of 
calcium, increased the blood calcium by 5. 7%. The administration of 
the high calcium buffer, which contained 2. 7 mg of calcium increased 
the blood calcium by 4. 5%. The difference observed between the two 
groups is due to the response of the pnimal to the level of hypercalcemia 
indu~ed by the administration of the two buffers. The high calcium 
> buffer produced a higher original hypercalcemia than when the normal 
buffer was administered and consequently induced the production of 
larger amounts of calcitonin, which in turn decreased the blood cal-
'::· cium. Another factor was probably involved; the hypercalcemia de-
.. ~··
•• pressed parathyroid function, which in turn decreased calcium mobiliza-
tion from bone. The combined effects resulted in a lesser plasma 
calcium increase observed for those animals receiving higher doses of 
calcium. 
The administration of the incubation- medium containing physiological 
concentrations of calcium (Table XII) decreased the plasma calcium by 
O. 76 mg. However, since calcium was injected with the medium it 
·~ 
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TABLE XII 
Effect of Krebs-Ringer Bicarbonate Buffer Containing Physiological 
and High Concentrations of Calcium on the Plasma Calcium of Rats. 
Physiological Buffer 
r Ca mg% 6.Ca mg% Animal 
No. to tso <tso - t ) 0 
1 11.20 11.03 - 0.17 
2 11.06 11.69 + 0.63 
3 10.71 11.64 + 0.93 
• 4 10.56 1.1. 43 + 0.87 
5 10.51 11.35 + 0.84 
+ + 0.62 + Mean - s. e. - 0.12 
High Calcium Buffer 
Animal 
·ca mg% 6.Ca mg% 
No. to tso <tso - t ) 0 
i 10.32 11.30 + 0.98 
2 11.. 24 11.50 + 0.26 
3 10.93 11.74 + 0.78 
4 10.38 10;86 + 0.48 
s· 11.28 11. 24 - 0.04 
+ + Mean - s. e. + 0.49 - 0.10 
- ' . ... . " . •. '" ., • . .;:. . '. " . ,. .. '": . ' : . " '~_, . ' . . ... ··' ~ ~ . : ',. ·>;·. .. ". - . . ' . 
Flask 
No. 
1 
2 
3 
4 
5 
+ Mean - s. e. 
TABLE XIII 
Serum Calcium Changes Induced by the Administration of Incubation 
Medi.a Containing Physiological Concentrations of Calcium. 
Ca mg% 6.Ca mg% Net 
* to t5o 2 5 µ.g Protein Effect 
10.83 9. 95 - 0.59 
-
1,21 
10.01 9.28 - 0.49 - 1. 11 
10.98 9.64 - 1.25 - 1.87 
9.67 9.44 - 0,21 - 0.83 
• 
10,29 9.15 - 0.93 - 1.55 
9.33 8.95 - o: 31 - 0.93 
11.09 10.11 - 0.74 
-
1.36 
10.52 9.12 - 1. 05 - 1.67 
10.90 9.76 - 0.99 - 1.61 
1.34 + 0,08 - -
% 
Change 
11.2 
11. 1 
17.0 
8.5 
15,1 
9.9 
12.2 
15,8 
14.7 
12. 8 
* Obtained by adding the mean of the change of the blood calcium of the control to the change 
of the blood calcium of each flask. 
• 
** . Per cent change from plasma calcium values at t 0 . 
** 
I 
"' ~
I 
TABLE XIV 
Serum Calcium Changes Induced bii: the Administration of Incubation 
Media Containing High Cone entr ations of Calcium. 
Flask Ca mg% 6.Ca mg% Net * % 
No, to t50 2 5 µ.g Protein Effect Change 
** 
1 10. 39 9.51 - 0,82 - 1,31 12.7 
10.70 9.24 - 1.36 - 1.85 17.3 
' ! 
2 11. 70 . 9. 93 - 1,53 - 2.02 17.3 
10.33 9.52 - 0.70 - 1.19 11, 5 I 
C1' 
... 
Ul 
3 10. 32 9.09 - 1.00 - 1.49 14.4 I 
10.51 9.32 - 0:91 - 1.40 13.3 
' 
4 11. 08 ' 9.21 - 1. 75 - 2.24 20.2 
' 
11.19 ! 10.11 - 1. 01 - 1. 50 13.4 i 
i 
5 11.60 10.10 - 1.34 - 1.83 15.7 
+ ' . + Mean - s. e. - 1.65 - 0.08 15.2 
PnysioJogi<pal High Calcium *** p 
+ 0.05 - 0.01 1.34 - 0.08 1.65 - 0.08 
*Obtained by adding the mean of the change of the blood calcium of the control {Table VI) to 
the change of the blood calcium for each flask. 
>~~~Per cent change from plasma calcium values at t 0 . . . **~:~Probability of the significance of the difference determined by the use of a Student's "t" statistic. 
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should be taken into account. By adding the change brought about by 
the vehicle (Table XII) we obtained the net change in. plasma calcium, 
i. 45 mg or 13. 6%. The administration of the incubation media contain-
ing high calcium concentrations (Table XIV) decreased the serum cal-
cium by 1. 17 mg. The net change is 1. 68 mg or 15. 4%. When the net 
change obtained by administering normal and high calcium incubation 
media are compared, we find that the difference of the means is statis-
tically significant~ indicating that the release of calcitonin is under the 
direct influence of calcium. 
Isolation and Purification of Galcitonin 
To determine whether the hypocalcemic activity that was observed 
~:, was due to calcitonin and not to some other unknown factor, calcitonin 
was isolated and purified. 200 grams of fresh glands were incubated 
in 50 ml Erlenmeyer flasks. Each flask contained 2. O grams of thyroid 
sliqes, 10 ml of Krebs-Ringer bicarbonate buffer containing high concen-
trations of calcium and 2. 5 µCi of glycine-C-14 (UL). The incubations 
were· carried on in an atmosphere of air at 37° C for four hours. After 
the incubations were terminated with trichloroacetic acid, the slices 
were minced and defatted. The def atted material was extracted with 
urea-cysteine...:HCL The extract was dialyzed against O. 1 M acetate 
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0 buffer for 24 hours at 4 C. The dialyzate was made 1. O M with 3. O 
0 M NaCl and allowed to stand 72 hours at 4 C. The inactive precipi-
tated protein was collected by centrifugation and discarded. To the 
supernatant was added solid NaCl to make a 2. O M solution and allowed 
0 
to stand 72 hours at 4 C. The active precipitate was collected by 
centrifugation and lyophilized. 
The lyophilized mat.erial weighed 120 mg. It was dissolved as 
completely as possible in 6. 5 ml of O. 1 M formic acid and the mixture 
centrifuged to remove suspended material. 4 ml of the supernatant was 
-
applied to a 40 x 2. 5 cm column of Sephadex G-100 and eluted with O. 1 
M formic acid. Figure 5 shows the elution pattern, the radioactivity 
and the protein content of each fraction as measured by the Lowry 
method (1956). The first 60 ml, the void volume, were discarded. 
The absorption at 280 mµ gave only one well-defined peak; however, 
when each fraction was analyzed for protein content by the Lowry 
method three protein peaks became evident. The hypocalcemic activity \ . . 
was confined entirely to the second protein peak. Radioactivity was 
high in the fractions containing hypocalcemic activity with 18, 000 DPM/ 
mg prbtein in fraction 6 and falling to 8, 000 DPM/mg protein in 
fraction 10. 
The fractions containing hypocalcemic activity were lyophilized 
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fractions collected. Hypocalcemic activity indicated by horizontal bar 
{ ' t ) • 
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and 1. 3 mg of solid material was obtained. 600 µg of this material, 
containing 456 µg of protein, were dissolved in O. 1 M acetic acid and 
used for the assay 9f hypocalcemic activity. This solution was diluted 
f :50 with O. 1 M acetic acid and 250 µl of the diluted solution, containing 
O. 56 µg protein, was injected into each rat. The hypocalcemic activity 
of this material is shown in Table XV. The average change in serum 
calcium is - O. 82 mg. When we add the change resulting from the 
vehicle alone, which is + O. 56 mg we obtain a net effect of - 1. 38 mg 
or an 11% drop in serum calcium. From the definition of a unit, O. 56 
• 
µ.g of protein is equivalent to 11 milliunits and 1. 0 mg of protein is 
equivalent to 19. 5 MRC units. 
700 p.g of the material obtained by lyophilizing the fractions from 
Sephadex G-100 containing hypocalcemic activity were dissolved in 350 
µ.l of 1. O M formic acid and applied to a 45 x O. 9 cm column of 
Sephadex G-50 superfine; it was then eluted with O. 1 M formic acid -
1. 0 M urea - O. 2 M NaCl. The elution pattern is shown in Figure 6. 
The hypocalcemic activity is confined to the main protein peak; radio-
activity was associated mainly with the fractions containing the hypo-
calceffi:iC activity~ The active fractions were pooled and lyophilized. 
The lyophilized material was dissolved in O. 1 M acetic' acid containing 
0.1% albumin and assayed for hypocalcemic activity. The albumin was 
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TABLE XV 
Hypocalcemic Activity of Lyophilized Fractions 
Animal 
No. 
1 
2 
3 
4 
5 
+ : 
Mean - s. e. 
from the Sephadex G-100 Column. 
Ca mg% 
to tso ti.Ca mgo/o 
• 
12.76 11.69 - 1.07 
. 
12.67 12.16 - 0.51 
12.29 11.51 - 0.78 
12.01 12.21 - 0.80 
11.94 11.00 - 0.94 
.... 
Net Effect ... 
D.Ca mg/O. 56 µg 
Protein 
- 1.62 
- 1.06 
- 1.33 
- 1.35 
- 1.49 
- 1.37 + - 0.09 
* . Obtained by adding the mean of the change of the serum calcium of the 
controls (Table VII) to the change of the serum calcium of each animal 
that received the experimental preparation. 
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FIGURE 6. Elution pattern of hypocalcemic activity from a Sephadex 
G-50 superfine column. Flow rate: 6 ml per hour; 1. O ml fractions 
were collected. The hypocalcemic activity was eluted as a single peak 
at fractions 16, 17 and 18. Hypocalcemic activity. 2x 
expansion of the % T scale. Protein content ( o ----- o ). Radioactivity 
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added to counteract the tendency of calcitonin to become adsorbed to 
. glass surface of the container (Parsons, 1967}. 140-170 gram rats 
were injected with 200 JJ.l of the calcitonin. solution into the femoral 
vein. The control animals received 200 µl of the lyophilized eluent 
used to elute calcitonin from the Sephadex G-50 column. The lyophilized 
eluent was dissolved in O. 1 M acetic acid and administered to the 
animals. The hypocalcemic activity is shown in Table XVI. Since 
O. 18 JJ.g of protein produces an 11. 7% fall in calcium, it can be calcu-
lated that the potency of the purified.calcitonin is 66. 5 MRC units per 
milligram protein. 
,. 
~ · Characterization of the Purified Calcitonin 
To assess the purity of the calcitonin obtained the individual 
fractions (16, 17 and 18} containing hypocalcemic activity were chromato-
graphed on a thin layer Eastman Chromatogram Sheet 6065 (cellulose 
with fluorescent indicator) and developed with the upper phase of a 
I . 
butanol: acetic acid: water (4:1:5) system for 2. 5 hours. The protein 
spots under short ultraviolet light (2 54 mµ) are visible as dark purple 
spots on a yellow fluorescent background. Only one spot for each 
fraction was visible (Figure 7). and it appears that the protein in each 
fraction is holl1:ogenous. Since the spots of all three fractions had the 
TABLE XVI 
Hypocalcemic Activity of Lyophilized Fractions from Sephadex G-50 Superfine 
++ ++ 
t::i.Ca mg% Net Effect* Animal Ca mg% (t0) Ca mg% (t50) per o. 18 µg 
No. Control Exper. Control Exper. Control Exper. Protein % Change 
1 10.86 10.93 11,16 10.13 + 0.42 - o. 80 - 1.26 11.5 
2 10.57 10.55 11.26 9.93 + o.69 - 0.62 - 1.39 13. 1 
... 
3 10.94 10.77 11.52 10,20 .+ 0.58 - 0.57 - 1.21 11.1 
4 10. 76 10, 85 11.18 10,09 + 0,30 - 0.76 - i,16 10,4 
5 10,66 11.52 11.64 10.85 + 0.98 - o.67 - 1.35 12.5 
+ 
- o.68 - 1.27 11.7 Mean - s. e. + 0.59 
* . Obtained by adding the mean of the (!hange of the blood of the calcium of the control animals 
to the change of the blood calciunJ; of eaiah .exp,,:rimental animal. 
·.,:r·. .._, 
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Solvent Front 
l 
a () 
r-
0 . . 
Origin 
Fraction No. (18) (17) (16) 
FIGURE 7. Reproduction of thin layer chromatogram of fractions 
containing hypocalcemic activity eluted from Sephadex G-50 superfine~ 
The chromatogram, on Eastman cellulose sheet with fluorescein indiC,ator· 
'I,·, 
was developed in a butanol: acetic acid: water (4:1:5) system for z •. Jf·. 
""-' 
hours. 
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same Rf value (0.116) the protein in all three fractions is presumably 
the same. 
An aliquot of the combined fractions was subjected to two-dimen-
sional chromatography. The chromatogram was developed in one 
direction with the upper phase of a butanol: acetic acid: water system 
and in the other direction with a propanol: water (70 :30) system.. Since 
only one spot was visible on the two-dimensional chromatogram (Figure 
8), it appears that the preparation was homogenous. 
To determine with certainty whether the protein was calcitonin or 
• 
not and whether it was contaminated by .other protein material 3. 0 µg 
protein was hydrolyzed for 24 hours at 110° C in 6. O N HCl. The 
hydrolysate was evaporated to dryness in a flash evaporator. and twice 
redissolved in water and dried again. After the last drying it was 
dissolved in 600 µl of O. 01 N HCl and analyzed for amino acids on a 
TSM Amino Acid Auto analyzer. Figure 9 shows the pattern of eluted 
amino acids. The absence of lysine and isoleucine are strong indica-
tions that the peptide is calcitonin. The glycine peak was collected and 
evaporated, almost to dryness, and diluted to 10 ml with water. A 100 
µl aliquot was measured for radioactivity and found to contain radio-
activity. 
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Sol vent Front 
( 1) 
. (2) 
Origin 
FIGURE 8. Reproduction of two-dimensional chromatogram of lyophilized 
hypocalcemic active fractions eluted from Sephadex G-50 superfine. The 
chromatogram on Eastman cellulose sheet was developed in direction 1 
with a butanol: acetic acid: water (4:1:5) system and in direction a ,with a 
propanol: water (70:30) system. 
100 
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CHAPTER IV 
DISCUSSION 
From information provided by previously reported studies on the 
i 
~ f in vitro biosynthesis of several polypeptide hormones (Adiga et al. 1965; 
f r.' Bauer and Lazarow, 1961; Mallory et al. 1964; Sacks, 1963; Steiner 
!· 
II f~ and Oyer, 1967) it appeared likely that the biosynthesis of calcitonin 
,_. 
" F· could be demonstrated in vitro. To our knowledge, no attempts have 
been made to demonstrate the synthesis of calcitonin. 
In this study the composition or the incubation medium necessary 
to give high incorporation of glycine-C-14 into the protein fraction of the 
thyroid tissue was defined. It was found that the addition of glucose 
(320 mg/100 ml) to Krebs-Ringer bicarbonate buffer (pH 7.4) increased 
incorporation markedly (200%). Glucose acts as the energy source for 
biosynthesis. The addition of the 15 amino acids of calcitonin to the 
Krebs-Ringer buffer had very little effect on the incorporation of label 
in proteins. In this instance, as was the case when no additions were 
made, the lack of an energy source would limit biosynthesis and, thus, 
the observed glycine-C-14 incorporation. The addition of both glucose 
and the 15 amino acids of calcitonin increased incorporation of glycine-
C-14 by 100%, less than when glucose alone was added. The reason 
for this inhibitory effect of the amino acids is not clear. In all the 
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incubations the buffer which contained both glucose and amino acids was 
used. The inhibitory effect of the amino acids is possibly due to the 
suppression of synthesis of thyroid proteins .in favor of the synthesis of 
those peptides that contain only the exogenously added amino acids . 
for the de novo synthesis of proteins would have to come from the 
limited pool of free amino acids already existing in the tissue slices, 
from breakdown of proteins and from gluconeogenesis, with the result 
that many peptides and proteins would be synthesized. When exogenous 
amino acids were added the system would use these preferentially 
• 
resulting in the preferential synthesis of those proteins and peptides 
made up of the exogenous amino acids, and since calcitonin is one of 
these peptides its synthesis would be preferentially stimulated. 
To demonstrate the synthesis of calcitonin, ovine thyroid glands 
0 
were incubated in Krebs-Ringer bicarbonate buffer for 4 hours at 37 C. 
After incubation the slices were defatted and extracted with 10 volumes 
of 8. 0 M urea - O. 1 M cysteine in O. 2 N HCI. The urea-cysteine-HCl 
system has been used with success in the extraction of calcitonin by 
Potts et al. (1967). For the isolation of calcitonin from the extract, the 
method of Gudmundsson et al. (1966) was used. Calcitonin was isolated 
through the second sodium chloride precipitation step. The precipitate 
was lyophilized, dissolved in O. 1 M acetic acid and administered intra-
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venously to 140-170 gram rats. When the hypocalcemic activity of 
incubated and non-incubated glands was compared, no difference was 
observed. Since calcitonin titers in the circulation seem to be con-
trolled by the blood calcium concentrations, the calcium concentration in 
the media was increased in an attempt to stimulate calcitonin synthesis. 
A four-fold increase in calcium markedly stimulates calcitonirt synthesis. 
In Vivo studies by Gitte$ et al. (1968) have shown that the extractable 
content of calcitonin in the thyroid gland is markedly reduced after 
hypercalcemic stimulation. Care et al. (1968), on the other hand, ob-
-.-
served no difference in the calcitonin content of the thyroids from pigs 
subjected to hypercalcemia and from normal pigs. Our results are in 
disagreement with the findings of Gittes and Care. The reason for the 
conflicting results is due to the different methods used. Both Gittes 
and Care. made their measurements in vivo, where measurements of 
the calcitonin content of the thyroid glands are complicated by the fact 
that during the time of perfusion with high calcium synthesis may occur, 
\ 
but it. may be masked by the continuous secretion and destruction of 
the hormone at the target organ. 
In an effort to determine whether the stimulation of calcitonin 
synthesis was a specific effect of calcium or whether magnesium could 
substitute for calcium, the concentration of magnesium was ·:Picifeased in 
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such a way that the ionic strength of the high calcium and high magnesium 
media were the same. Magnesium was chosen because about 60% of the 
total body magnesium is located on the surface of bone, incapable of 
penetration into the lattiCe interior. It exchanges for calcium in bone on 
a mole-for-mole basis (Blaxter, 1956). It has also been shown that the 
levels of serum and urinary magnesium are controlled by parathyroid hor-
mone in a manner simil~r to that of calcium (Bethune et al. 1968). The 
results of this study show that magnesium did not significantly affect 
the synthesis of calcitonin, therefore, the mechanism by which calcium 
,,. 
stimulates the synthesis of calcitonin is· not affected by magnesium. The 
molecular basis for the calcium activation of the synthesis of this particu-
~ lar peptide is completely unknown. It may increase the uptake of amino ~ 
f- •• 
' ~; acids by the cells; in the parathyroid it has been shown to decrease the 
uptake of the amino acid analog o.-aminoisobutyric acid (Raisz and 
0 1Brien, 1963). Further studies would be needed to establish how cal-
cium brings about its effect. 
\ 
When calcitonin is injected into rats it produces hypocalcemia 
which starts a few minutes after administration of the hormone and 
reaches a maximum at about one hour and returns to normal within 
three hours (Kumar et al. 1965; Hirsch et al. 1964). It has been 
demonstrated both in vivo (Milhaud et al. · 1965b;. Martin et al. 1966) and 
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in vitro (Friedman and Raisz, 1965; Aliapoulios et al. 1966) that calci-
tonin produces its hypocalcemic response by inhibiting bone resorption. 
Macintyre (1967) has shown that the hormone is biologically active on 
isolated, perfused cat tibia proving that the effect is a direct one. The 
mechanism that controls the titer of the circulating hormone seems to 
be similar to that controlling parathyroid hormone. Secretion of para-
thyroid hormone has been shown to be controlled by blood calcium con -
centration; hypocalcemia enhancing ·secretion and hypercalcemia abolishing 
secretion (Sherwood et al. 1968). Calcitonin has also been shown to be 
dependent upon blood calcium. Work by Care et al. (1967) indicated 
that the secretion of calcitonin was controlled by a negative feedback 
which operated through the blood calcium concentration. Care et al. 
(1968) measured the secretion of calcitonin in pigs in vivo and were able 
to demonstrate that there was a linear relationship between calcitonin in 
the venous blood and the concentration of calcium in the perfusing 
medium over a range of calcium of 6-10 meq/liter. Below 6 meq/liter 
of calcium they were not able to detect calcitonin. Lee et al. (1969) 
have shown that calcitonin is secreted at normal blood calcium concentra-
. tions and even below. The manner by which calcium controls the 
secretion rate of calcitonin is unclear. It could act directly on the 
secretion granules of the C cells or its action may be mediated by an un -
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, known messenger. Gittes and Irvin (1965) suggested that a parathyroid 
factor may have been responsible for release of calcitonin; subsequent 
studies, however, f!'liled to confirm their hypothesis (Foster, 1968; 
Toverud et al. 1966). Control of calcitonin secretion by the pituitary 
gland has been investigated and there is no evidence of such a control 
(Milhaud and Mauktar, 1965). Recently Avioli et al. (1968) have found 
that calcitonin is released by glucagon. The results obtained in this 
investigation support the hypothesis that calcium exerts a direct effect 
on the release of calcitonin from the thyroid gland; in fact, an increase 
• 
in the concentration of calcium in the incubation media led to an in-
crease in the release of the hormone. From the data obtained, it can 
be calculated that the glands incubated in Krebs-Ringer buffer containing 
a high calcium concentration, 500 MRC milliunits, of calcitonin were 
released per gram of glands per 4 hours. ·The glands incubated in 
buffer containing physiological. concentrations of calcium released 442 
MRC milliunits calcitonin per gram per 4 hours. 
\ 
Since the hypocalcemic effect observed upon administration of the 
calcitonin preparations may have been the result of some unknown im-
purity,_ the hormone was purified. For purification the method of 
Gudmundsson et al. (1966) was used. · The lyophilized material, obtained 
by precipitation in 2. O M NaCl, was dissolved in O. 1 M formic acid 
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and applied to a Sephadex G-100 column. The fractions containing 
hypocalcemic activity were combined and lyophilized. The lyophilized 
material was found to have very high biological activity; O. 56 µg protein 
lowered the serum calcium of rats by 11% which corresponds to 11 MRC 
milliunits activity by definition; it can be calculated that the activity of 
this fraction was 19. 5 MRC units per mg protein. 700 µg of the 
lyophilizate was dissolved in 0. 35 ml of 1. O M formic acid and applied 
to a 45 x O. 9 mm column of Sephadex G-50 superfine. The hypocalce-
mic activity was found in fractions 16, 17 and 18. These three 
• 
fractions comprised the main protein peak. These fractions were com-
( 
~ bined and lyophilized and the hypocalcemic activity assayed. It was 
found that O. 18 µg of protein decreased the serum calcium of rats by 
12%, which is equivalent to 12 MRC milliunits ·activity or 66. 7 MRC 
units per milligram protein. The activity of chemically synthesized 
calcitonin is much higher. about 200 MRC per milligram. The lower 
activity of our preparation is possibly due to denaturation which 
occurred during isolation and purification, or to species differences. 
The protein in all three fractions was homogenous on thin layer 
chromatography and the Rf value was the. same, indicating that the pro-
tein was identical in the three fractions. An aliquot of the pooled 
fractions was found to be homogenous on two-dimensional thin layer 
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chromatography. Amino acid analysis of an aliquot of the combined 
.. 
fractions was found to lack both lysine and isoleucine and since porcine 
calcitonin lacks these two amino acids, it is further proof that calci-
tonin was actually isolated and purified, and that the hypocalcemic 
activity observed was due to calcitonin and not to some other unknown 
agent. However, the possibility that ovine calcitonin has an amino 
1~ acid composition different than porcine calcitonin should be considered, 
since human calcitonin has been found to have many amino acid residues 
which are not found in the porcine hormone (Neher et al. 1968) . 
• 
The possibility that calcitonin can· be synthesized in an in vitro 
system opens the way for further studies. The hormone with a radio-
active label can be used to trace the locus of action at the cellular 
level at the target organs. The mechanism and the site of synthesis 
can be studied by the use of protein synthesis inhibitors and cellular 
fractionation. Since the hormone is present in granules in the C cells 
it would be of interest to study the locus of synthesis and the trans-
port of the hormone to the granules. Another aspect of calcitonin 
synthesis amenable to study with the system developed in this investiga-
·tion is. whether the hormone is synthesiz~d as a 32 amino acid poly-
peptide or whether it has a precursor molecule, and if so, when and 
how it is transformed into the biologically active polypeptide which is 
found in the thyroid glands. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
Recently the in vitro biosynthesis of polypeptide hormones has 
been reported. In this investigation was presented a method for the 
biosynthesis of calcitonin in ovine thyroid slices. Ovine thyroid tissue 
is contaminated with the inferior parathyroid tissue, whereas the 
{. 
-
superior parathyroids are anatomically separated. We did not attempt 
to separate the parathyroid .tissue, since the calcitonin synthesizing 
• cells are "adventitious" to the thyroid a,nd in some species to the 
parathyroids and thymus (Macintyre, 1968); furthermore, since it is 
now well established that there is only one calcitonin it was thought that 
if the sheep parathyroid tissue contained C cells the calcitonin synthesized 
by these cells would not interfere with the purpose of our work. The 
biosynthesis of the hormone opens the way for studies on the mechanism 
and control of synthesis and release of the hormone. 
In this study it was attempted to establish the role played by 
calcium in the regulation of synthesis and release of calcitonin. It has 
been shown that in vivo calcitonin increases in the serum of animals in 
response to a hypercalcemic stimulus. In vivo studies, however, cannot 
discern whether the hypercalcemia increases synthesis, release or both. 
The results presented in this investigation show that calcium increases 
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both the synthesis and release of the hormone. Other factors may 
exist. and recently Avioli et al. (1968) has found evidence that glucagon 
may release calcitonin from the thyroid glands. If this is true the 
effect of glucagon is probably not related to the calcium effect. since 
calcium can act in vitro. and the effect is a specific property of the 
calcium ion. In fact. magnesium cannot substitute for calcium. This 
may have been anticipated since calcitonin does not affect magnesium 
levels in the blood (Gitelman et al. 1965}. 
The purified hormone was foundi to have very high specific activity. 
approximately 67 MRC units per m~ligram protein. The hormone was 
found to be pure and homogenous by thin layer chromatography and 
amino acid analysis. 
" 
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ABSTRACT 
Abstract of the dissertation entitled "THE IN VITRO BIOSYNTHESIS 
OF CALCITONIN" s.ubmitted by Nino Sorgente in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy, June, 1969. 
Slices of ovine thyroid glands were incubated (4 hr.. 31° C) with 
glycine-C-14 in Krebs-Ringer bicarbonate buffer (pH 7. 4) containing 
glucose (320 mg/ 100 ml) and the amino acids of calcitonin (20 mg/l). 
Calcitonin was isolated by sodium chloride precipitation from the 
incubated slices. and the hypocalcerrtic activity assayed in 140-170 gram 
rats fasted for 18 hours. The hypocalcemic activity was expressed as 
the. change in serum calcium between time O and 50 minutes per 10 or 
25 µg protein of the calcitonin preparation. 
The hypocalcemic activity of calcitonin isolated from glands 
incubated in buffer containing physiological concentrations of calcium 
(ii. 5 mg%) was not significantly different from the hypocalcemic activity 
of calcifonin isolated from unincubated glands. However, when the 
h:ypocalcemic activity of calcitonin isolated from slices incubated in 
buffer containing high concentrations of calcium (45. 6 mg%) was com-
pared to the hypocalcemic activity of calcitonin isolated from slices 
incubated in buffer containing physiological concentrations of calcium, it 
was found that ·the hypocalcemic activity increased 50%. An increase 
in the magnesimn concentration of the buffer from 3. 7 mg% to 29. 8 mg% 
had no significant effect on the hypocalcemic activity of the calcitonin 
preparations. 
To determine whether calcium had an effect on the release of 
calcitonin from the glands, at the end of the incubation the media was 
assayed for hypocalcemic activity. A significant increase in hypocalcemic 
activity was found in the incubation media containing high concentrations 
of calcium as compared to the media containing physiological concentr.a-
tions of calcium. 
The calcitonin from incubated slices was isolated by sodium 
chloride precipitation and purified by" pa.ssage of the isolated material on 
columns of Sephadex G-100 and Sephadex G-50 superfine. The purified 
material was homogeneous on thin layer chromatography and contained 
very high hypocalcemic activity (66. 5 MRC units per milligram protein). 
The purified material was subjected to amino acid analysis, and it was 
found to contain all amino acids of porcine calcitonin, except leucine, 
phenylalanine and tyrosine. The glycine peak was collected and was 
\ 
found to 'contain radioactivity. 
In this work, a method for the biosynthesis of calcitonin in ovine thy-
roid slices was developed. Using this method it has been shown that both the 
synthesis and release of calcitonin are under the control of calcium ions. 
Magnesium ions cannot substitute for calcium to stimulate the synthesis of 
calcitonin. 
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